Equity Details
Price & Market Data
Price: $79.04
Daily Change: +$1.30 / 1.64%
Daily Range: $76.59 - $79.59
Market Cap: $11,133,339,648
Daily Volume: 1,533,352
Performance Metrics
1 Week: 5.49%
1 Month: 23.91%
3 Months: 25.62%
6 Months: 101.5%
1 Year: 465.8%
YTD: 19.05%
About Arrowhead Pharmaceuticals, Inc. (ARWR)
Analyze the market position of Arrowhead Pharmaceuticals, Inc. (ARWR). With a current price of 79.04, the stock exhibits a +$1.30 / 1.64% daily trend. A market capitalization of 11,133,339,648 indicates its scale. Discover its performance over 1-month (23.91%) and 3-month (25.62%) periods.
Company Details
Employees: 711
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.